• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在门诊环境中,对 IOTA 逻辑回归模型 LR1 和 LR2 与主观模式识别进行前瞻性评估,以诊断卵巢癌。

Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting.

机构信息

Gynaecological Diagnostic Outpatient Treatment Unit, University College Hospital, London, UK.

Department of Statistical Science, University College London, London, UK.

出版信息

Ultrasound Obstet Gynecol. 2018 Jun;51(6):829-835. doi: 10.1002/uog.18918. Epub 2018 Jun 4.

DOI:10.1002/uog.18918
PMID:28976616
Abstract

OBJECTIVE

To determine whether International Ovarian Tumor Analysis (IOTA) logistic regression models LR1 and LR2 developed for the preoperative diagnosis of ovarian cancer could also be used to differentiate between benign and malignant adnexal tumors in the population of women attending gynecology outpatient clinics.

METHODS

This was a single-center prospective observational study of consecutive women attending our gynecological diagnostic outpatient unit, recruited between May 2009 and January 2012. All the women were first examined by a Level-II ultrasound operator. In those diagnosed with adnexal tumors, the IOTA-LR1/2 protocol was used to evaluate the masses. The LR1 and LR2 models were then used to assess the risk of malignancy. Subsequently, the women were also examined by a Level-III examiner, who used pattern recognition to differentiate between benign and malignant tumors. Women with an ultrasound diagnosis of malignancy were offered surgery, while asymptomatic women with presumed benign lesions were offered conservative management with a minimum follow-up of 12 months. The initial diagnosis was compared with two reference standards: histological findings and/or a comparative assessment of tumor morphology on follow-up ultrasound scans. All women for whom the tumor classification on follow-up changed from benign to malignant were offered surgery.

RESULTS

In the final analysis, 489 women who had either or both of the reference standards were included. Their mean age was 50 years (range, 16-91 years) and 45% were postmenopausal. Of the included women, 342/489 (69.9%) had surgery and 147/489 (30.1%) were managed conservatively. The malignancy rate was 137/489 (28.0%). Overall, sensitivities of LR1 and LR2 for the diagnosis of malignancy were 97.1% (95% CI, 92.7-99.2%) and 94.9% (95% CI, 89.8-97.9%) and specificities were 77.3% (95% CI, 72.5-81.5%) and 76.7% (95% CI, 71.9-81.0%), respectively (P > 0.05). In comparison with pattern recognition (sensitivity 94.2% (95% CI, 88.8-97.4%), specificity 96.3% (95% CI, 93.8-98.0%)), the specificities of the IOTA models were significantly lower (P < 0.0001). A significantly higher number of women would have been offered surgery for suspected cancer if the women had been assessed using the IOTA models instead of pattern recognition (213/489 (43.6%) vs 142/489 (29.0%); P < 0.001).

CONCLUSIONS

The IOTA models maintained their high sensitivity when used in an outpatient setting. Specificity was relatively low, which indicates that a significant proportion of the women would have been offered unnecessary surgery for suspected ovarian cancer. These findings show that the IOTA models could be used as a first-stage test to diagnose ovarian cancer in an outpatient setting, but a different second-stage test is required to minimize the number of false-positive findings. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

摘要

目的

确定国际卵巢肿瘤分析(IOTA)逻辑回归模型 LR1 和 LR2 是否也可用于区分妇科门诊就诊的女性的良性和恶性附件肿瘤。

方法

这是一项单中心前瞻性观察性研究,连续纳入 2009 年 5 月至 2012 年 1 月在我院妇科诊断门诊就诊的女性。所有女性均首先由二级超声操作员进行检查。对于诊断为附件肿瘤的患者,采用 IOTA-LR1/2 方案评估肿块。然后使用 LR1 和 LR2 模型评估恶性肿瘤的风险。随后,由三级检查者进行检查,使用模式识别来区分良性和恶性肿瘤。超声诊断为恶性肿瘤的女性被建议手术,而无症状的疑似良性病变的女性则接受保守治疗,至少随访 12 个月。初始诊断与两个参考标准进行比较:组织学发现和/或随访超声扫描的肿瘤形态比较评估。所有肿瘤分类在随访中从良性变为恶性的女性均被建议手术。

结果

最终分析纳入了 489 名具有任何一种参考标准或两种参考标准的女性。她们的平均年龄为 50 岁(范围 16-91 岁),45%为绝经后女性。在纳入的女性中,342/489(69.9%)接受了手术,147/489(30.1%)接受了保守治疗。恶性肿瘤发生率为 137/489(28.0%)。总体而言,LR1 和 LR2 诊断恶性肿瘤的敏感度分别为 97.1%(95%CI,92.7-99.2%)和 94.9%(95%CI,89.8-97.9%),特异性分别为 77.3%(95%CI,72.5-81.5%)和 76.7%(95%CI,71.9-81.0%)(P>0.05)。与模式识别(敏感度 94.2%(95%CI,88.8-97.4%),特异性 96.3%(95%CI,93.8-98.0%))相比,IOTA 模型的特异性显著较低(P<0.0001)。如果使用 IOTA 模型而不是模式识别来评估女性,将有更多的女性被建议手术治疗疑似癌症(213/489(43.6%)vs 142/489(29.0%);P<0.001)。

结论

IOTA 模型在门诊环境中保持了较高的敏感度。特异性相对较低,这表明很大一部分女性将被建议进行不必要的疑似卵巢癌手术。这些发现表明,IOTA 模型可用作门诊诊断卵巢癌的第一阶段测试,但需要使用不同的第二阶段测试来减少假阳性发现的数量。版权所有©2017ISUOG。由 John Wiley & Sons Ltd 出版。

相似文献

1
Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting.在门诊环境中,对 IOTA 逻辑回归模型 LR1 和 LR2 与主观模式识别进行前瞻性评估,以诊断卵巢癌。
Ultrasound Obstet Gynecol. 2018 Jun;51(6):829-835. doi: 10.1002/uog.18918. Epub 2018 Jun 4.
2
A prospective validation of the IOTA logistic regression models (LR1 and LR2) in comparison to subjective pattern recognition for the diagnosis of ovarian cancer.前瞻性验证 IOTA 逻辑回归模型(LR1 和 LR2)与主观模式识别在卵巢癌诊断中的应用。
Int J Gynecol Cancer. 2013 Nov;23(9):1583-9. doi: 10.1097/IGC.0b013e3182a6171a.
3
Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.病灶大小影响 IOTA 逻辑回归模型、IOTA 简单规则和恶性风险指数在鉴别附件包块良恶性方面的诊断性能。
Ultrasound Obstet Gynecol. 2012 Sep;40(3):345-54. doi: 10.1002/uog.11167. Epub 2012 Aug 7.
4
Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two-step strategy using benign descriptors and ADNEX model: Portuguese multicenter study.前瞻性验证 IOTA 方法对附件包块的分类,以及使用良性描述符和 ADNEX 模型对两步策略的回顾性评估:葡萄牙多中心研究。
Ultrasound Obstet Gynecol. 2024 Oct;64(4):538-549. doi: 10.1002/uog.27641. Epub 2024 Sep 4.
5
Intra- and interobserver agreement when describing adnexal masses using the International Ovarian Tumor Analysis terms and definitions: a study on three-dimensional ultrasound volumes.使用国际卵巢肿瘤分析术语和定义描述附件包块时的观察者内和观察者间一致性:一项关于三维超声体积的研究。
Ultrasound Obstet Gynecol. 2013 Mar;41(3):318-27. doi: 10.1002/uog.12289.
6
Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.对 IOTA 三步法特征描述和分类附件包块的前瞻性外部验证,以及使用简单规则风险的替代两步法的回顾性评估。
Ultrasound Obstet Gynecol. 2019 May;53(5):693-700. doi: 10.1002/uog.20163.
7
Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.基于超声的逻辑回归模型 LR2 与磁共振成像鉴别附件良恶性肿块:一项前瞻性研究。
Int J Clin Oncol. 2018 Jun;23(3):514-521. doi: 10.1007/s10147-017-1222-y. Epub 2017 Dec 13.
8
Prospective evaluation of the IOTA logistic regression model LR2 for the diagnosis of ovarian cancer.IOTA 逻辑回归模型 LR2 对卵巢癌诊断的前瞻性评估。
Ultrasound Obstet Gynecol. 2012 Sep;40(3):355-9. doi: 10.1002/uog.11088.
9
Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group.基于超声的逻辑回归模型对附件包块进行卵巢癌预测:IOTA 小组的时间和外部验证研究。
Ultrasound Obstet Gynecol. 2010 Aug;36(2):226-34. doi: 10.1002/uog.7636.
10
Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.IOTA ADNEX 模型在中国妇科肿瘤中心评估附件肿块的性能。
Ultrasound Obstet Gynecol. 2019 Dec;54(6):815-822. doi: 10.1002/uog.20363. Epub 2019 Nov 11.

引用本文的文献

1
Ultrasound-guided cyst aspiration for management of acute adnexal torsion.超声引导下囊肿抽吸术治疗急性附件扭转
Ultrasound Obstet Gynecol. 2025 Jun;65(6):790-797. doi: 10.1002/uog.29225. Epub 2025 Apr 26.
2
A modified CEUS risk stratification model for adnexal masses with solid components: prospective multicenter study and risk adjustment.改良的附件区实性肿块超声造影风险分层模型:前瞻性多中心研究和风险调整。
Eur Radiol. 2024 Sep;34(9):5978-5988. doi: 10.1007/s00330-024-10639-1. Epub 2024 Feb 19.
3
Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study.
中文医师应用 IOTA SRR 和 LR2 评分系统鉴别中国患者良恶性附件包块的对比诊断准确性:一项回顾性观察性研究。
BMC Womens Health. 2023 Nov 8;23(1):585. doi: 10.1186/s12905-023-02719-z.
4
A novel predictive model of microvascular invasion in hepatocellular carcinoma based on differential protein expression.基于差异蛋白表达的肝细胞癌微血管侵犯新型预测模型。
BMC Gastroenterol. 2023 Mar 27;23(1):89. doi: 10.1186/s12876-023-02729-z.
5
Diagnostic Performances of Ultrasound-Based Models for Predicting Malignancy in Patients with Adnexal Masses.基于超声的模型对附件包块患者恶性肿瘤预测的诊断性能
Healthcare (Basel). 2022 Dec 20;11(1):8. doi: 10.3390/healthcare11010008.
6
Surgical outcomes of adnexal masses classified by IOTA ultrasound simple rules.根据 IOTA 超声简单规则分类的附件包块的手术结果。
Sci Rep. 2022 Dec 17;12(1):21848. doi: 10.1038/s41598-022-26441-2.
7
Comparison of diagnostic efficiency between IOTA LR2 model and doctors experiences.IOTA LR2 模型与医生经验的诊断效率比较。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Aug 28;47(8):1082-1088. doi: 10.11817/j.issn.1672-7347.2022.220051.
8
Diagnostic Performance of the Ovarian-Adnexal Reporting and Data System (O-RADS) Ultrasound Risk Score in Women in the United States.美国女性卵巢-附件报告和数据系统(O-RADS)超声风险评分的诊断性能。
JAMA Netw Open. 2022 Jun 1;5(6):e2216370. doi: 10.1001/jamanetworkopen.2022.16370.
9
A comparison of the diagnostic performance of the O-RADS, RMI4, IOTA LR2, and IOTA SR systems by senior and junior doctors.资深医生和初级医生对O-RADS、RMI4、IOTA LR2和IOTA SR系统诊断性能的比较。
Ultrasonography. 2022 Jul;41(3):511-518. doi: 10.14366/usg.21237. Epub 2022 Jan 31.
10
Significance of Pelvic Fluid Observed during Ovarian Cancer Screening with Transvaginal Sonogram.经阴道超声检查在卵巢癌筛查中观察到盆腔积液的意义。
Diagnostics (Basel). 2022 Jan 7;12(1):144. doi: 10.3390/diagnostics12010144.